Found: 69
Select item for more details and to access through your institution.
Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications.
- Published in:
- 2015
- By:
- Publication type:
- journal article
STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics.
- Published in:
- 2019
- By:
- Publication type:
- journal article
cDC2 plasticity and acquisition of a DC3‐like phenotype mediated by IL‐6 and PGE2 in a patient‐derived colorectal cancer organoids model.
- Published in:
- European Journal of Immunology, 2024, v. 54, n. 6, p. 1, doi. 10.1002/eji.202350891
- By:
- Publication type:
- Article
PGE2‐EP4 signaling steers cDC2 maturation toward the induction of suppressive T‐cell responses.
- Published in:
- European Journal of Immunology, 2024, v. 54, n. 3, p. 1, doi. 10.1002/eji.202350770
- By:
- Publication type:
- Article
Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry.
- Published in:
- European Journal of Immunology, 2024, v. 54, n. 1, p. 1, doi. 10.1002/eji.202350616
- By:
- Publication type:
- Article
Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 6, p. 1494, doi. 10.1002/eji.202048580
- By:
- Publication type:
- Article
DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 4, p. 1014, doi. 10.1002/eji.201040790
- By:
- Publication type:
- Article
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37933-8
- By:
- Publication type:
- Article
PD‐L1 in gestational trophoblastic disease: an antibody evaluation.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2022, v. 101, n. 9, p. 1007, doi. 10.1111/aogs.14404
- By:
- Publication type:
- Article
Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1392, doi. 10.3390/ijms24021392
- By:
- Publication type:
- Article
Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 1, p. 273, doi. 10.3390/ijms19010273
- By:
- Publication type:
- Article
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 65, doi. 10.3390/vaccines6030065
- By:
- Publication type:
- Article
Fluorine labelling of therapeutic human tolerogenic dendritic cells for <sup>19</sup>F-magnetic resonance imaging.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.988667
- By:
- Publication type:
- Article
Spatial and Temporal Heterogeneity of Tumor-Infiltrating Lymphocytes in Advanced Urothelial Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.802877
- By:
- Publication type:
- Article
Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.768957
- By:
- Publication type:
- Article
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 12, p. 3945, doi. 10.1245/s10434-019-07274-2
- By:
- Publication type:
- Article
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 11, p. 1407, doi. 10.1038/nbt1154
- By:
- Publication type:
- Article
A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.
- Published in:
- Mediators of Inflammation, 2016, p. 1, doi. 10.1155/2016/3605643
- By:
- Publication type:
- Article
Dendritic cell immunotherapy: mapping the way.
- Published in:
- Nature Medicine, 2004, v. 10, n. 5, p. 475, doi. 10.1038/nm1039
- By:
- Publication type:
- Article
Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome.
- Published in:
- BMC Immunology, 2012, v. 13, n. 1, p. 71, doi. 10.1186/1471-2172-13-71
- By:
- Publication type:
- Article
Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.02489
- By:
- Publication type:
- Article
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02265
- By:
- Publication type:
- Article
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01412
- By:
- Publication type:
- Article
Interleukin-15-Induced CD56<sup>+</sup> Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051851
- By:
- Publication type:
- Article
Multicore Liquid Perfluorocarbon‐Loaded Multimodal Nanoparticles for Stable Ultrasound and <sup>19</sup>F MRI Applied to In Vivo Cell Tracking.
- Published in:
- Advanced Functional Materials, 2019, v. 29, n. 19, p. N.PAG, doi. 10.1002/adfm.201806485
- By:
- Publication type:
- Article
Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 1, p. 137, doi. 10.1007/s00262-022-03234-0
- By:
- Publication type:
- Article
Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 9, p. 1425, doi. 10.1007/s00262-018-2204-2
- By:
- Publication type:
- Article
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 10, p. 1573, doi. 10.1007/s00262-010-0833-1
- By:
- Publication type:
- Article
Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 7, p. 1109, doi. 10.1007/s00262-008-0626-y
- By:
- Publication type:
- Article
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E<sub>2</sub> results in high interleukin-12 production and cell migration.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1589, doi. 10.1007/s00262-008-0489-2
- By:
- Publication type:
- Article
Dendritic Cells Require PINK1-Mediated Phosphorylation of BCKDE1α to Promote Fatty Acid Oxidation for Immune Function.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02386
- By:
- Publication type:
- Article
Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00824
- By:
- Publication type:
- Article
Whole Blood Transcriptome Profiling Identifies DNA Replication and Cell Cycle Regulation as Early Marker of Response to Anti-PD-1 in Patients with Urothelial Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4660, doi. 10.3390/cancers13184660
- By:
- Publication type:
- Article
Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2345, doi. 10.3390/cancers13102345
- By:
- Publication type:
- Article
Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2249, doi. 10.3390/cancers13092249
- By:
- Publication type:
- Article
Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2692, doi. 10.3390/cancers12092692
- By:
- Publication type:
- Article
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
- Published in:
- Nature Reviews Immunology, 2007, v. 7, n. 10, p. 790, doi. 10.1038/nri2173
- By:
- Publication type:
- Article
EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1355769
- By:
- Publication type:
- Article
Liposomes loaded with vitamin D3 induce regulatory circuits in human dendritic cells.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1137538
- By:
- Publication type:
- Article
Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1119371
- By:
- Publication type:
- Article
Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1105244
- By:
- Publication type:
- Article
The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.724883
- By:
- Publication type:
- Article
Recent Advances and Future Perspective of DC-Based Therapy in NSCLC.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.704776
- By:
- Publication type:
- Article
PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.641703
- By:
- Publication type:
- Article
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.631713
- By:
- Publication type:
- Article
Subsets of CD1c<sup>+</sup> DCs: Dendritic Cell Versus Monocyte Lineage.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.559166
- By:
- Publication type:
- Article
Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 10, p. 2354, doi. 10.1002/ijc.23756
- By:
- Publication type:
- Article
Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 5, p. 978, doi. 10.1002/ijc.22385
- By:
- Publication type:
- Article
Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 1, p. 67, doi. 10.1002/ijc.22118
- By:
- Publication type:
- Article